The Updated 2022 WHO PitNET Classification: Understanding Controversies, Limitations, and Clinical Impact

The Updated 2022 WHO PitNET Classification: Understanding Controversies, Limitations, and Clinical Impact

Does standardizing classification of pituitary tumours expand the role of the endocrinologist and extend patient access to resources?​ Join us as we explore the scientific rationale behind the WHO classification system and its impact on clinical practice.

Faculty
Dr. Stan Van Uum, Western University, London (Chair)
Dr. Shereen Ezzat, University of Toronto, Toronto (Speaker)
Dr. Michelle Johnson, Providence Health, Vancouver (Speaker)
Dr. Sandra Cooke-Hubley, Memorial University, St. John's (Speaker)

At the end of this session participants will be able to:

• Outline the principles of the WHO PitNET classification
• Describe the impact on management of patients with pituitary tumors by endocrinologists
  
• Discuss the controversies and limitations of the classification system within the Canadian healthcare system

This session is free for CSEM members and $100 for non-members. 
If you have not yet renewed your CSEM membership for 2023, you can renew now.

Microsite: https://csem-scem.bespokeav.ca/PitNet/

This program is co-developed with Pfizer Canada and planned independently by CSEM to achieve scientific integrity, validity and balance.